Beyond Clinical Remission: Redefining Disease Control in Severe Asthma?
作者信息
Kim Yeonhee, Song Woo-Jung
机构信息
Division of Allergy and Clinical Immunology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
出版信息
Allergy Asthma Immunol Res. 2025 Jul;17(4):405-408. doi: 10.4168/aair.2025.17.4.405.
PMID:40736770
Abstract
摘要
相似文献
[1]
Beyond Clinical Remission: Redefining Disease Control in Severe Asthma?
Allergy Asthma Immunol Res. 2025-7
[2]
[3]
[4]
[5]
[6]
[7]
Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
Ann Allergy Asthma Immunol. 2025-6-20
[8]
Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging.
Am J Respir Crit Care Med. 2025-9
[9]
[10]
本文引用的文献
[1]
[2]
[3]
[4]
Biologics in severe asthma: a state-of-the-art review.
Eur Respir Rev. 2025-1-8
[5]
On-treatment clinical remission of severe asthma with real-world longer-term biologic use.
J Allergy Clin Immunol Glob. 2024-10-30
[6]
[7]
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
J Allergy Clin Immunol Pract. 2024-12
[8]
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR.
Allergy Asthma Immunol Res. 2024-5
[9]
Remission in the World of Severe Asthma.
Am J Respir Crit Care Med. 2024-10-1
Zotero 插件